Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Total Debt (2016 - 2025)

Historic Total Debt for INVO Fertility (IVF) over the last 14 years, with Q3 2025 value amounting to $5.4 million.

  • INVO Fertility's Total Debt rose 4957.46% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year increase of 4957.46%. This contributed to the annual value of $3.6 million for FY2024, which is 333.73% down from last year.
  • As of Q3 2025, INVO Fertility's Total Debt stood at $5.4 million, which was up 4957.46% from $6.0 million recorded in Q2 2025.
  • Over the past 5 years, INVO Fertility's Total Debt peaked at $6.1 million during Q1 2025, and registered a low of $185458.0 during Q1 2021.
  • Moreover, its 4-year median value for Total Debt was $3.7 million (2024), whereas its average is $3.2 million.
  • Over the last 5 years, INVO Fertility's Total Debt had its largest YoY gain of 23191.03% in 2024, and its largest YoY loss of 333.73% in 2024.
  • Quarter analysis of 4 years shows INVO Fertility's Total Debt stood at $340539.0 in 2021, then skyrocketed by 1002.37% to $3.8 million in 2023, then dropped by 3.34% to $3.6 million in 2024, then surged by 49.81% to $5.4 million in 2025.
  • Its Total Debt stands at $5.4 million for Q3 2025, versus $6.0 million for Q2 2025 and $6.1 million for Q1 2025.